Adaptive Biotechnologies Corporation (ADPT) Stock

Healthcare · Diagnostics & Research · Member of Other US Stocks

Adaptive Biotechnologies Corporation (ADPT) closed at USD 25.58 on 2026-10-15, a change of +52.3 % over the past year, with a market capitalization of USD 3.83B.

Adaptive Biotechnologies Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Adaptive Biotechnologies Corporation key figures

Previous close

USD 25.58 (2026-10-15)

1-year change

+52.3 %

Market cap

USD 3.83B

Enterprise value

USD 3.91B

P/E ratio (trailing)

-58.59

P/E ratio (forward)

-133.23

EPS (trailing)

-0.41

EPS (forward)

-0.18

PEG ratio

n/a

Price to book

26.75

Revenue growth

21.5 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.27

Employees

624

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Adaptive Biotechnologies Corporation and compare it with other stocks.